IBDEI01C ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1305,1,3,0)
 ;;=3^SCREEN-RICKETTSIAL DIS
 ;;^UTILITY(U,$J,358.3,1305,1,4,0)
 ;;=4^V75.0
 ;;^UTILITY(U,$J,358.3,1305,2)
 ;;=^295641
 ;;^UTILITY(U,$J,358.3,1306,0)
 ;;=V75.1^^15^108^39
 ;;^UTILITY(U,$J,358.3,1306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1306,1,3,0)
 ;;=3^SCREEN-MALARIA
 ;;^UTILITY(U,$J,358.3,1306,1,4,0)
 ;;=4^V75.1
 ;;^UTILITY(U,$J,358.3,1306,2)
 ;;=^295642
 ;;^UTILITY(U,$J,358.3,1307,0)
 ;;=V75.2^^15^108^36
 ;;^UTILITY(U,$J,358.3,1307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1307,1,3,0)
 ;;=3^SCREEN-LEISHMANIASIS
 ;;^UTILITY(U,$J,358.3,1307,1,4,0)
 ;;=4^V75.2
 ;;^UTILITY(U,$J,358.3,1307,2)
 ;;=^295643
 ;;^UTILITY(U,$J,358.3,1308,0)
 ;;=V75.3^^15^108^61
 ;;^UTILITY(U,$J,358.3,1308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1308,1,3,0)
 ;;=3^SCREEN-TRYPANOSOMIASIS
 ;;^UTILITY(U,$J,358.3,1308,1,4,0)
 ;;=4^V75.3
 ;;^UTILITY(U,$J,358.3,1308,2)
 ;;=^295644
 ;;^UTILITY(U,$J,358.3,1309,0)
 ;;=V75.4^^15^108^43
 ;;^UTILITY(U,$J,358.3,1309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1309,1,3,0)
 ;;=3^SCREEN-MYCOTIC INFECT
 ;;^UTILITY(U,$J,358.3,1309,1,4,0)
 ;;=4^V75.4
 ;;^UTILITY(U,$J,358.3,1309,2)
 ;;=^295645
 ;;^UTILITY(U,$J,358.3,1310,0)
 ;;=V75.5^^15^108^56
 ;;^UTILITY(U,$J,358.3,1310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1310,1,3,0)
 ;;=3^SCREEN-SCHISTOSOMIASIS
 ;;^UTILITY(U,$J,358.3,1310,1,4,0)
 ;;=4^V75.5
 ;;^UTILITY(U,$J,358.3,1310,2)
 ;;=^295646
 ;;^UTILITY(U,$J,358.3,1311,0)
 ;;=V75.6^^15^108^22
 ;;^UTILITY(U,$J,358.3,1311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1311,1,3,0)
 ;;=3^SCREEN-FILARIASIS
 ;;^UTILITY(U,$J,358.3,1311,1,4,0)
 ;;=4^V75.6
 ;;^UTILITY(U,$J,358.3,1311,2)
 ;;=^295647
 ;;^UTILITY(U,$J,358.3,1312,0)
 ;;=V75.7^^15^108^29
 ;;^UTILITY(U,$J,358.3,1312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1312,1,3,0)
 ;;=3^SCREEN-HELMINTHIASIS
 ;;^UTILITY(U,$J,358.3,1312,1,4,0)
 ;;=4^V75.7
 ;;^UTILITY(U,$J,358.3,1312,2)
 ;;=^295648
 ;;^UTILITY(U,$J,358.3,1313,0)
 ;;=V75.8^^15^108^48
 ;;^UTILITY(U,$J,358.3,1313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1313,1,3,0)
 ;;=3^SCREEN-PARASITIC DIS NEC
 ;;^UTILITY(U,$J,358.3,1313,1,4,0)
 ;;=4^V75.8
 ;;^UTILITY(U,$J,358.3,1313,2)
 ;;=^295649
 ;;^UTILITY(U,$J,358.3,1314,0)
 ;;=V76.0^^15^108^77
 ;;^UTILITY(U,$J,358.3,1314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1314,1,3,0)
 ;;=3^SCRN MAL NEOP RESP ORG
 ;;^UTILITY(U,$J,358.3,1314,1,4,0)
 ;;=4^V76.0
 ;;^UTILITY(U,$J,358.3,1314,2)
 ;;=^295651
 ;;^UTILITY(U,$J,358.3,1315,0)
 ;;=V76.10^^15^108^66
 ;;^UTILITY(U,$J,358.3,1315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1315,1,3,0)
 ;;=3^SCRN MAL NEOP BREAST
 ;;^UTILITY(U,$J,358.3,1315,1,4,0)
 ;;=4^V76.10
 ;;^UTILITY(U,$J,358.3,1315,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,1316,0)
 ;;=V76.11^^15^108^71
 ;;^UTILITY(U,$J,358.3,1316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1316,1,3,0)
 ;;=3^SCRN MAL NEOP MAMMO HIGH RISK PT
 ;;^UTILITY(U,$J,358.3,1316,1,4,0)
 ;;=4^V76.11
 ;;^UTILITY(U,$J,358.3,1316,2)
 ;;=^317969
 ;;^UTILITY(U,$J,358.3,1317,0)
 ;;=V76.12^^15^108^70
 ;;^UTILITY(U,$J,358.3,1317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1317,1,3,0)
 ;;=3^SCRN MAL NEOP MAMMO
 ;;^UTILITY(U,$J,358.3,1317,1,4,0)
 ;;=4^V76.12
 ;;^UTILITY(U,$J,358.3,1317,2)
 ;;=^317970
 ;;^UTILITY(U,$J,358.3,1318,0)
 ;;=V76.2^^15^108^67
 ;;^UTILITY(U,$J,358.3,1318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1318,1,3,0)
 ;;=3^SCRN MAL NEOP CERVIX
 ;;^UTILITY(U,$J,358.3,1318,1,4,0)
 ;;=4^V76.2
 ;;^UTILITY(U,$J,358.3,1318,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,1319,0)
 ;;=V76.3^^15^108^65
 ;;^UTILITY(U,$J,358.3,1319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1319,1,3,0)
 ;;=3^SCRN MAL NEOP BLADDER
 ;;^UTILITY(U,$J,358.3,1319,1,4,0)
 ;;=4^V76.3
 ;;^UTILITY(U,$J,358.3,1319,2)
 ;;=^295654
 ;;^UTILITY(U,$J,358.3,1320,0)
 ;;=V76.41^^15^108^76
 ;;^UTILITY(U,$J,358.3,1320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1320,1,3,0)
 ;;=3^SCRN MAL NEOP RECTUM
 ;;^UTILITY(U,$J,358.3,1320,1,4,0)
 ;;=4^V76.41
 ;;^UTILITY(U,$J,358.3,1320,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,1321,0)
 ;;=V76.42^^15^108^73
 ;;^UTILITY(U,$J,358.3,1321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1321,1,3,0)
 ;;=3^SCRN MAL NEOP ORAL CAV
 ;;^UTILITY(U,$J,358.3,1321,1,4,0)
 ;;=4^V76.42
 ;;^UTILITY(U,$J,358.3,1321,2)
 ;;=^295656
 ;;^UTILITY(U,$J,358.3,1322,0)
 ;;=V76.43^^15^108^78
 ;;^UTILITY(U,$J,358.3,1322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1322,1,3,0)
 ;;=3^SCRN MAL NEOP SKIN
 ;;^UTILITY(U,$J,358.3,1322,1,4,0)
 ;;=4^V76.43
 ;;^UTILITY(U,$J,358.3,1322,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,1323,0)
 ;;=V76.44^^15^108^75
 ;;^UTILITY(U,$J,358.3,1323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1323,1,3,0)
 ;;=3^SCRN MAL NEOP PROSTATE
 ;;^UTILITY(U,$J,358.3,1323,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,1323,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,1324,0)
 ;;=V76.45^^15^108^79
 ;;^UTILITY(U,$J,358.3,1324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1324,1,3,0)
 ;;=3^SCRN MAL NEOP TESTIS
 ;;^UTILITY(U,$J,358.3,1324,1,4,0)
 ;;=4^V76.45
 ;;^UTILITY(U,$J,358.3,1324,2)
 ;;=^321549
 ;;^UTILITY(U,$J,358.3,1325,0)
 ;;=V76.46^^15^108^74
 ;;^UTILITY(U,$J,358.3,1325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1325,1,3,0)
 ;;=3^SCRN MAL NEOP OVARY
 ;;^UTILITY(U,$J,358.3,1325,1,4,0)
 ;;=4^V76.46
 ;;^UTILITY(U,$J,358.3,1325,2)
 ;;=^322084
 ;;^UTILITY(U,$J,358.3,1326,0)
 ;;=V76.47^^15^108^80
 ;;^UTILITY(U,$J,358.3,1326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1326,1,3,0)
 ;;=3^SCRN MAL NEOP VAGINA
 ;;^UTILITY(U,$J,358.3,1326,1,4,0)
 ;;=4^V76.47
 ;;^UTILITY(U,$J,358.3,1326,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,1327,0)
 ;;=V76.51^^15^108^69
 ;;^UTILITY(U,$J,358.3,1327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1327,1,3,0)
 ;;=3^SCRN MAL NEOP INTESTINE
 ;;^UTILITY(U,$J,358.3,1327,1,4,0)
 ;;=4^V76.51
 ;;^UTILITY(U,$J,358.3,1327,2)
 ;;=^322089
 ;;^UTILITY(U,$J,358.3,1328,0)
 ;;=V76.81^^15^108^72
 ;;^UTILITY(U,$J,358.3,1328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1328,1,3,0)
 ;;=3^SCRN MAL NEOP NERVOUS SYSTEM
 ;;^UTILITY(U,$J,358.3,1328,1,4,0)
 ;;=4^V76.81
 ;;^UTILITY(U,$J,358.3,1328,2)
 ;;=^322091
 ;;^UTILITY(U,$J,358.3,1329,0)
 ;;=V77.0^^15^108^59
 ;;^UTILITY(U,$J,358.3,1329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1329,1,3,0)
 ;;=3^SCREEN-THYROID DISORDER
 ;;^UTILITY(U,$J,358.3,1329,1,4,0)
 ;;=4^V77.0
 ;;^UTILITY(U,$J,358.3,1329,2)
 ;;=^295661
 ;;^UTILITY(U,$J,358.3,1330,0)
 ;;=V77.1^^15^108^18
 ;;^UTILITY(U,$J,358.3,1330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1330,1,3,0)
 ;;=3^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,1330,1,4,0)
 ;;=4^V77.1
 ;;^UTILITY(U,$J,358.3,1330,2)
 ;;=^295662
 ;;^UTILITY(U,$J,358.3,1331,0)
 ;;=V77.2^^15^108^40
 ;;^UTILITY(U,$J,358.3,1331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1331,1,3,0)
 ;;=3^SCREEN-MALNUTRITION
 ;;^UTILITY(U,$J,358.3,1331,1,4,0)
 ;;=4^V77.2
 ;;^UTILITY(U,$J,358.3,1331,2)
 ;;=^295663
 ;;^UTILITY(U,$J,358.3,1332,0)
 ;;=V77.3^^15^108^49
 ;;^UTILITY(U,$J,358.3,1332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1332,1,3,0)
 ;;=3^SCREEN-PHENYLKETONURIA
 ;;^UTILITY(U,$J,358.3,1332,1,4,0)
 ;;=4^V77.3
 ;;^UTILITY(U,$J,358.3,1332,2)
 ;;=^295664
 ;;^UTILITY(U,$J,358.3,1333,0)
 ;;=V77.4^^15^108^23
 ;;^UTILITY(U,$J,358.3,1333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1333,1,3,0)
 ;;=3^SCREEN-GALACTOSEMIA
 ;;^UTILITY(U,$J,358.3,1333,1,4,0)
 ;;=4^V77.4
 ;;^UTILITY(U,$J,358.3,1333,2)
 ;;=^295665
 ;;^UTILITY(U,$J,358.3,1334,0)
 ;;=V77.5^^15^108^27
 ;;^UTILITY(U,$J,358.3,1334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1334,1,3,0)
 ;;=3^SCREEN-GOUT
 ;;^UTILITY(U,$J,358.3,1334,1,4,0)
 ;;=4^V77.5
 ;;^UTILITY(U,$J,358.3,1334,2)
 ;;=^295666
 ;;^UTILITY(U,$J,358.3,1335,0)
 ;;=V77.6^^15^108^15
 ;;^UTILITY(U,$J,358.3,1335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1335,1,3,0)
 ;;=3^SCREEN-CYSTIC FIBROSIS
 ;;^UTILITY(U,$J,358.3,1335,1,4,0)
 ;;=4^V77.6
 ;;^UTILITY(U,$J,358.3,1335,2)
 ;;=^295667
 ;;^UTILITY(U,$J,358.3,1336,0)
 ;;=V77.7^^15^108^33
 ;;^UTILITY(U,$J,358.3,1336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1336,1,3,0)
 ;;=3^SCREEN-INBORN ERR METAB
 ;;^UTILITY(U,$J,358.3,1336,1,4,0)
 ;;=4^V77.7
 ;;^UTILITY(U,$J,358.3,1336,2)
 ;;=^295668
 ;;^UTILITY(U,$J,358.3,1337,0)
 ;;=V77.8^^15^108^46
 ;;^UTILITY(U,$J,358.3,1337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1337,1,3,0)
 ;;=3^SCREEN-OBESITY
 ;;^UTILITY(U,$J,358.3,1337,1,4,0)
 ;;=4^V77.8
 ;;^UTILITY(U,$J,358.3,1337,2)
 ;;=^295669
 ;;^UTILITY(U,$J,358.3,1338,0)
 ;;=V77.91^^15^108^38
 ;;^UTILITY(U,$J,358.3,1338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1338,1,3,0)
 ;;=3^SCREEN-LIPOID DISORDERS
 ;;^UTILITY(U,$J,358.3,1338,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,1338,2)
 ;;=^322093
 ;;^UTILITY(U,$J,358.3,1339,0)
 ;;=V78.0^^15^108^34
 ;;^UTILITY(U,$J,358.3,1339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1339,1,3,0)
 ;;=3^SCREEN-IRON DEFIC ANEMIA
 ;;^UTILITY(U,$J,358.3,1339,1,4,0)
 ;;=4^V78.0
 ;;^UTILITY(U,$J,358.3,1339,2)
 ;;=^295671
 ;;^UTILITY(U,$J,358.3,1340,0)
 ;;=V78.1^^15^108^16
 ;;^UTILITY(U,$J,358.3,1340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1340,1,3,0)
 ;;=3^SCREEN-DEFIC ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,1340,1,4,0)
 ;;=4^V78.1
 ;;^UTILITY(U,$J,358.3,1340,2)
 ;;=^295672
 ;;^UTILITY(U,$J,358.3,1341,0)
 ;;=V78.2^^15^108^57
 ;;^UTILITY(U,$J,358.3,1341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1341,1,3,0)
 ;;=3^SCREEN-SICKLE CELL DIS
 ;;^UTILITY(U,$J,358.3,1341,1,4,0)
 ;;=4^V78.2
 ;;^UTILITY(U,$J,358.3,1341,2)
 ;;=^295673
 ;;^UTILITY(U,$J,358.3,1342,0)
 ;;=V78.3^^15^108^30
 ;;^UTILITY(U,$J,358.3,1342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1342,1,3,0)
 ;;=3^SCREEN-HEMOGLOBINOPATH NEC
 ;;^UTILITY(U,$J,358.3,1342,1,4,0)
 ;;=4^V78.3
 ;;^UTILITY(U,$J,358.3,1342,2)
 ;;=^295674
 ;;^UTILITY(U,$J,358.3,1343,0)
 ;;=V79.0^^15^108^17
 ;;^UTILITY(U,$J,358.3,1343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1343,1,3,0)
 ;;=3^SCREEN-DEPRESSION
